Lupin Share Price Target 2023, 2024, 2025 to 2030: Can Lupin Reach 3000INR by 2030?

Lupin is a multinational pharma corporation with headquartered in Mumbai, Maharashtra. Paediatrics, anti-infectives, cardiovascular, asthma, diabetology and anti-tuberculosis are among the company’s primary emphasis areas. Lupin Limited is also one of the top 100 stocks in the Indian stock market by market capitalization. Lupin is now ranked 64th among the top 100 stocks.

Lupin was also included on Forbes’ list of the top 2000 global corporations. Lupin’s net sales amount to Rs.12,700 crore. In terms of revenue volume, this makes it India’s largest pharmaceutical firm. Analyze its financials below to determine Lupin Share price targets for future investments.


  • Lupin Limited obtained FDA approval for darunavir tablets. It’s a generic version of Janssen’s Prezista.
  • Lupin launches DIFIZMA, an asthma drug.
  • Lupin’s Q3 Profit Drops 72% to INR 153 Crore Amid High Comparison Base, Revenue Increases 4%

How to buy Lupin Shares in 2023?

Some of the following websites can be used to buy the stocks:

  • Zerodha
  • Upstox
  • Groww
  • AngelOne
  • ICICIDirect

LUPIN Share Price Target 2023-2030

Lupin Stock Value Predictions displays a substantial increase in the upcoming forecast period, ensuring its investors a high long-term return. The Lupin share price target 2030 will be Rs. 3218.84 at its peak.

LUPIN Share Price Target 2023 is 1019.52INR

When Maximum Price Minimum Price
February 2023 ₹729.90 ₹654.54
March 2023 ₹669.93 ₹608.40
April 2023 ₹626.92 ₹582.24
May 2023 ₹522.43 ₹401.87
June 2023 ₹626.92 ₹482.24
July 2023 ₹752.30 ₹578.69
August 2023 ₹827.53 ₹636.56
September 2023 ₹868.91 ₹668.39
October 2023 ₹827.53 ₹636.56
November 2023 ₹910.28 ₹700.22
December 2023 ₹1,019.52 ₹784.24

Lupin share price in March, April and May 2023 looks bearish. The year 2023 has its ups and downs, but it appears to be a prosperous year for shareholders overall. Despite the fact that the year begins with a maximum share price of Rs. 745, it may fall to Rs. 608.40 in March. This could be because of Lupin’s weak FY22Q3 earning report. Because of this, Lupins share price could drop to ₹401.87 in May 2023.

However, this should not be cause for concern because Lupin’s share price target is expected to revive in July and continue to rise steadily.

Long-term investors will most certainly profit this year. Lupin stock value forecasts for December will hit a high of Rs. 1,019.52.

LUPIN Share Price Target 2024

Lupin Stock price Target Maximum Price Minimum Price
January 2024 1097.514394 979.55854
February 2024 1237.643705 1016.039732
March 2024 1358.013914 1234.558104
April 2024 1234.558104 1122.325549
May 2024 1028.79842 935.2712906
June 2024 1234.558104 1122.325549
July 2024 1296.286009 1178.441826
August 2024 1425.91461 1296.286009
September 2024 1497.21034 1361.100309
October 2024 1425.91461 1296.286009
November 2024 1468.692048 1335.174589
December 2024 1498.065889 1361.878081

The Lupin shares price forecast is expected to remain relatively stable in 2024. At the beginning of the year, the maximum possible value is 1097.51INR, and the lowest possible value is 979.55INR. At the end of the year, it is anticipated that the price of Lupin stock will reach a target of Rs. 1498.06 in the month of December.


When Maximum Price Minimum Price
January 2025 1423.162595 1293.784177
February 2025 1352.004465 1229.094968
March 2025 1419.604688 1290.549716
April 2025 1267.504186 1152.276532
May 2025 1377.721941 1252.474492
June 2025 1515.494135 1377.721941
July 2025 1443.327748 1312.116134
August 2025 1312.116134 1192.832849
September 2025 1377.721941 1252.474492
October 2025 1312.116134 1192.832849
November 2025 1377.721941 1252.474492
December 2025 1474.162477 1340.147706

The Lupin share price target 2025 is exciting opportunity for stockholders since it promises a significant overall capital gain. Those who invest in the Lupin share price target 2025 will benefit from a steady increase throughout the year. Moreover, the December 2025 price forecast for Lupin shares is Rs. 1474.16.


Year WISE (in INR) Maximum Price Minimum Price
2026 1739.511723 1565.56055
2027 2104.809184 1894.328266
2028 2525.771021 2273.193919
2029 2980.409805 2682.368825
2030 3218.84259 2896.958331

Lupin Share Price Target by Motital Oswal

Motilal Oswal has downgraded Indian pharmaceutical company Lupin to a “sell” rating, citing a 72% drop in their Q3 profits to Rs 153 crore, which the brokerage attributes to a high base from the previous year.

The brokerage has also reduced their price target for Lupin to INR 610, which is lower than their previous target. The downgraded rating and reduced price target reflect Motilal Oswal’s negative outlook on Lupin’s financial performance in the near future.

You can read more on that here.


What is Lupin’s 52-week high and low?

Lupin’s share price has ranged between Rs 797.50 and Rs 583.00 in the previous 52 weeks.

What is Lupin’s market capitalization?

Lupin stock is ranked 11 in the Pharmaceuticals industry by market capitalization. Lupin has a market cap of Rs 29,82 Thousand Crore INR.

How can I do a quick review of Lupin stock?

Lupin’s Key Metrics are Lupin’s PE ratio is -15.63, its earnings per share is -47.50, its price/sales ratio is 2.07, and its price to book ratio is 2.69. 

What is Lupin’s Share Price target 2030?

Maximum Lupin share price target for 2030 is Rs. 3218.84259, whereas the minimum expected share price is Rs. 2896.958331.

What is Lupin’s Share Price target for 2025?

The maximum Lupin share price target for 2025 is Rs. 1474.162477. And the minimum expected price for Lupin shares is Rs. 1152.276532.

Further Reading:

Final Conclusion: Should you have Lupin in your Portfolio?

The experts arrived to the following conclusion, after considering nearly every element of stocks. The Price Trend analysis reveals that it is Weak, indicating that Lupin Ltd.’s price is expected to fall in the short term. Long-term investors, on the other hand, have an entirely different tale.

We are aware that the whole pharmaceutical industry is in turmoil as a result of the USFDA. This is why, for the past few years, a stock like Lupin has underperformed. It is expected that equities such as Lupin would ultimately emerge from this. However, it may take some time. Lupin will stay feeble till then.

This stock is best suited for long-term investors. There is, indeed, a risk. Lupin, on the other hand, is a premier corporation. The firm recorded a Composite Total Income of Rs 4194.99 Crore for the quarter ended 31-12-2021, up.74% over the previous quarter’s. Total income of Rs 4164.14 crore, increasing 3.87% from the same quarter previous year.

Income of Rs 4038.53 crore. In the most recent quarter, the company generated a net profit after tax of Rs 549.06 crore. Lupin Ltd. got a buy call from Emkay Global with a target price of Rs 1100. Lupin Ltd. is currently trading at Rs 738.1. The analyst has assigned a time frame of one year for Lupin Ltd.’s price to achieve the specified objective.

According to my analysis, Lupin is in consolidation mode, and may move upwards after a few more months of downfall. I think it could be a good Pharma stock to buy in 2023 (but not the best), once it start posting positive results. However, I would not be buying Lupin myself at this point in time. I think there are other better Pharma stocks to hold that Lupin. Some of these are Sun Pharma, Cipla etc.

Author: Sudiksha GhoshI'm Sudiksha Ghosh, and I like writing content. I've been working in this field since 2019, and every day I learn something new. My prior experiences have made me quite resourceful, and I have a keen interest in research.

Leave a Reply